Pharmacological use of uridine in the treatment of nervous disorders
US4960759A · kind A · utility
18Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 1989 |
| Grant date | Oct 2, 1990 |
| Priority date | — |
| Expiry date | Jun 19, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disorders due to an altered balance of dopamine release by the cerebral dopaminergic system, such as schizophrenia and Parkinson's disease, can be treated by administration of uridine which is a specific agent for the protection of the cholecystokinin level in the brain tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.